A PINK1 activator
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

MTK 458

Item No. 41391

Technical Information
Formal Name
N-[(1R)-1,2,3,4-tetrahydro-1-naphthalenyl]-6-(trifluoromethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
CAS Number
2499962-58-0
Synonyms
  • EP-0035985
Molecular Formula
C17H15F3N4
Formula Weight
Purity
≥98%
Formulation
A solid
DMSO: Sparingly soluble: 1-10 mg/ml
SMILES
FC(F)(C1=CC2=C(N[C@@H]3CCCC4=CC=CC=C43)N=CN=C2N1)F
InChi Code
InChI=1S/C17H15F3N4/c18-17(19,20)14-8-12-15(21-9-22-16(12)24-14)23-13-7-3-5-10-4-1-2-6-11(10)13/h1-2,4,6,8-9,13H,3,5,7H2,(H2,21,22,23,24)/t13-/m1/s1
InChi Key
JOIONRWKOGDQOG-CYBMUJFWSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    MTK 458 is a PTEN-inducible putative kinase 1 (PINK1) activator.1 It, in combination with the mitochondria uncoupler FCCP (Item No. 15218), increases levels of PINK1 and phosphorylated ubiquitin (pUb) in HeLa cervical cancer cells when used at a concentration of 6.6 µM. MTK 458, in combination with FCCP, induces mitophagy in HeLa cells (EC50 = 0.44 µM). It inhibits doxycycline-induced increases in the mitochondrial levels of insoluble ornithine transcarbamylase (OTC) in HeLa cells when used at concentrations of 25 or 50 µM. In vivo, MTK 458 (50 mg/kg per day) decreases the midbrain levels of total α-synuclein and insoluble α-synuclein aggregates in a mouse model of Parkinson's disease induced by α-synuclein injection in the ipsilateral striatum.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. De Roulet, D., Bartholomeus, J., Johnstone, S., et alCompositions and methods of using the same for treatment of neurodegenerative and mitochondrial disease. (2020).